Recombinant Human BMPR2 (C-Fc-6His)

Bone Morphogenetic Protein Receptor II (BMPR-II) is a Type II Serine/Threonine Kinase that mediates cellular responses to BMPs. BMPR-II is characterized by lacking of a GS domain, and presence of a C-terminal extension typical of type II receptors. BMPRII binds BMP2, BMP4 and BMP7 weakly in the absence of type I receptor, and the binding can be facilitated by the presence of the type I receptor, including BMPR-IA/Brk1, BMPR-IB, and ActR-I. BMPR-II plays a key role in cell growth. Defects in BMPR-II have been linked to primary pulmonary hypertension. Human and mouse BMPR-II are highly conserved and share 97 % amino acid sequence identity.

Bone Morphogenetic Protein Receptor Type-2; BMP Type-2 Receptor; BMPR-2; Bone Morphogenetic Protein Receptor Type II; BMP Type II Receptor; BMPR-II; BMPR2; PPH1

Always centrifuge tubes before opening.Do not mix by vortex or pipetting.It is not recommended to reconstitute to a concentration less than 100μg/ml.Dissolve the lyophilized protein in distilled water.Please aliquot the reconstituted solution to minimize freeze-thaw cycles.

Store at -70°C/-20°C, stable for 6 months after receipt.Store at ≤-70°C, stable for 3 months under sterile conditions after opening. Please minimize freeze-thaw cycles.

Recombinant Human Bone Morphogenetic Protein Receptor Type IIA is produced by our Mammalian expression system and the target gene encoding Ser27-Ile151 is expressed with a human IgG1 Fc, 6His tag at the C-terminus.